[1]
Sisay, M. et al. 2016. THE MOLECULAR TRIAD SYSTEM INVOLVING RANK/RANKL/OPG AS THERAPEUTIC TARGETS FOR METABOLIC BONE DISEASES. Journal of Drug Delivery and Therapeutics. 6, 6 (Nov. 2016), 31–39. DOI:https://doi.org/10.22270/jddt.v6i6.1341.